Metagenomi, Inc. (MGX)
NASDAQ: MGX · IEX Real-Time Price · USD
3.607
-0.193 (-5.08%)
Jun 21, 2024, 12:59 PM EDT - Market open

Metagenomi Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
202320222021
Cash & Equivalents
145.85190.5143.4
Short-Term Investments
130.58177.6968.86
Cash & Cash Equivalents
276.43368.2112.25
Cash Growth
-24.92%228.01%-
Receivables
2.4500
Other Current Assets
-0.61-1.31-3.34
Total Current Assets
278.27366.9108.92
Property, Plant & Equipment
65.1533.2621.89
Long-Term Investments
10.687.816.42
Other Long-Term Assets
10.746.524.77
Total Long-Term Assets
86.5747.5933.08
Total Assets
364.84414.49141.99
Accounts Payable
1.792.011.35
Deferred Revenue
78.99110.1339.76
Current Debt
3.431.520.69
Other Current Liabilities
-15.35-65.12-16.63
Total Current Liabilities
68.8648.5425.17
Long-Term Debt
44.817.0648.24
Other Long-Term Liabilities
36.0177.2224.63
Total Long-Term Liabilities
80.8194.2772.87
Total Liabilities
149.67142.8198.04
Total Debt
48.2318.5748.93
Debt Growth
159.70%-62.04%-
Retained Earnings
-144.94-76.69-33.1
Comprehensive Income
-0.1-0.27-0.02
Shareholders' Equity
-135.58-74.43-32.54
Net Cash / Debt
228.2349.6363.33
Net Cash / Debt Growth
-34.73%452.12%-
Net Cash Per Share
67.03102.8519.44
Working Capital
209.41318.3683.74
Book Value Per Share
-39.82-21.89-9.99
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).